These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15316127)

  • 21. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
    J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
    Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
    J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of a single gene-encoded single-chain-tetravalent antitumor antibody.
    Santos AD; Kashmiri SV; Hand PH; Schlom J; Padlan EA
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3118s-3123s. PubMed ID: 10541352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of human germline genes in a CDR homology-based approach to antibody humanization.
    Hwang WY; Almagro JC; Buss TN; Tan P; Foote J
    Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
    Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
    BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humanization of high affinity anti-HBs antibody by using human consensus sequence and modification of selected minimal positional template and packing residues.
    Tiwari A; Khanna N; Acharya SK; Sinha S
    Vaccine; 2009 Apr; 27(17):2356-66. PubMed ID: 19428851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of synthetic polypeptide domains of carcinoembryonic antigen and their use in epitope mapping.
    Hass GM; Bolling TJ; Kinders RJ; Henslee JG; Mandecki W; Dorwin SA; Shively JE
    Cancer Res; 1991 Apr; 51(7):1876-82. PubMed ID: 1706220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy.
    Lee YC; Boehm MK; Chester KA; Begent RH; Perkins SJ
    J Mol Biol; 2002 Jun; 320(1):107-27. PubMed ID: 12079338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications.
    Yazaki PJ; Shively L; Clark C; Cheung CW; Le W; Szpikowska B; Shively JE; Raubitschek AA; Wu AM
    J Immunol Methods; 2001 Jul; 253(1-2):195-208. PubMed ID: 11384681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humanization of a chicken anti-IL-12 monoclonal antibody.
    Tsurushita N; Park M; Pakabunto K; Ong K; Avdalovic A; Fu H; Jia A; Vásquez M; Kumar S
    J Immunol Methods; 2004 Dec; 295(1-2):9-19. PubMed ID: 15627607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humanization of an anti-human TNF-alpha antibody by variable region resurfacing with the aid of molecular modeling.
    Zhang W; Feng J; Li Y; Guo N; Shen B
    Mol Immunol; 2005 Aug; 42(12):1445-51. PubMed ID: 15950738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression, purification, and characterization of a two domain carcinoembryonic antigen minigene (N-A3) in pichia pastoris. The essential role of the N-domain.
    You YH; Hefta LJ; Yazaki PJ; Wu AM; Shively JE
    Anticancer Res; 1998; 18(5A):3193-201. PubMed ID: 9858883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.
    Carmichael JA; Power BE; Garrett TP; Yazaki PJ; Shively JE; Raubischek AA; Wu AM; Hudson PJ
    J Mol Biol; 2003 Feb; 326(2):341-51. PubMed ID: 12559905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An ELISA for quantification of T84.66, a monoclonal anti-CEA antibody, in mouse plasma.
    Urva SR; Yang VC; Balthasar JP
    J Immunoassay Immunochem; 2010; 31(1):1-9. PubMed ID: 20391013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody humanization by framework shuffling.
    Dall'Acqua WF; Damschroder MM; Zhang J; Woods RM; Widjaja L; Yu J; Wu H
    Methods; 2005 May; 36(1):43-60. PubMed ID: 15848074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of engineered antibodies.
    Hwang WY; Foote J
    Methods; 2005 May; 36(1):3-10. PubMed ID: 15848070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.